Abstract:Objective To evaluate the value of contrast-enhanced ultrasound (CEUS) in preoperative classification for hilar cholangiocarcinoma. Methods Forty-six patients with 46 hilar cholangiocarcinoma were diagnosed by surgical pathology in Zhongshan Hospital of Fudan University from January 2007 to April 2013. The echogenicity difference on conventinal ultrasound and CEUS were compared with chi-square test. The accuracy of conventinal ultrasound and CEUS for evaluating invaded bile duct, detective rates for portal vein invasion and displaying rate of metastatic hilar lymph nodes were compared with chi-square test or Fisher’s Exact test according to the golden standard of operative exploration. Results On CEUS, 82.6%(38/46) and 91.3%(42/46) hilar cholangiocarcinoma were hypoechoic in portal vein phase and delayed phase respectively, while 63.0%(29/46) hilar cholangiocarcinoma were isoechoic on conventinal ultrasound with vague margin. The clearly displaying rates were 37.0%(17/46), 84.8%(39/46) and 91.3%(42/46) in conventinal ultrasound, portal vein and delayed phase of CEUS and the echogenicity was signiifcantly different. The evaluation accuracy of hilar cholangiocarcinoma invading bile duct was improved from 80.4%(37/46, conventinal ultrasound) to 100%(46/46, CEUS) significantly (χ2=7.882,P=0.005). Portal vein invasion were found in 9 cases during operative exploration and the detective rates on conventinal ultrasound and CEUS were 78%(7/9) and 89%(8/9) without signiifcant difference (P=1.000). Metastatic hilar lymph nodes were found in 8 cases and the displaying rates on conventinal ultrasound and CEUS were the same (75%, 6/8) without signiifcant difference (P=1.000). Conclusions CEUS could signiifcantly improve the clearly displaying rate of hilar cholangiocarcinoma and improve the evaluation accuracy for invaded bile duct comparing with conventinal ultrasound.

The value of contrast-enhanced harmonic ultrasound for hilar cholangiocarcinoma

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Value of SonoVue-enhanced grey scale ultrasonography for differential diagnosis of benign and malignant neoplasms of the gallbladder

The role of real-time contrast-enhanced ultrasonography in the diagnosis of liver metastasis

Assessment of vascularity of hepatocellular carcinoma with real-time contrast-enhanced sonography

The role of new contrast agent and contrast-enhanced gray-scale ultrasound in the diagnosis of liver neoplasms

Evaluation of treatment response in hepatocellular carcinoma with contrast-enhanced harmonic sonography

ULTRASONIC DIAGNOSIS OF EXTRAHEPATIC CHOLANGIOCARCINOMA

Hemodynamic analysis of real-time enhanced-ultrasonography in diagnosis of focal liver lesions

Comparison of enhancement features of hepatic tumors on SonoVue-enhanced real-time gray-scale ultrasonography and contrast-enhanced helical CT

Value of contrast-enhanced ultrasound in preoperative evaluation for hilar cholangiocarcinoma

Enhancement pattern of atypical liver haemangioma with contrast-enhanced ultrasound

Comparison of enhancement features of hepatic tumors on contrast-enhanced ultrasonography and helical CT

Effects of post-contrast enhanced ultrasonography on characterization of focal liver lesions

Clinical value of contrast-enhanced ultrasonography in diagnosis of testicular torsion

Contrast-enhanced ultrasound in liver tumors

Study of clear cell carcinoma of the liver using contrast enhanced ultrasound

Primarily diagnostic criteria of focal liver lesions using contrast enhanced ultrasound

Differentiation diagnosis of contrast enhancing inflammatory liver lesions and hepatocellular carcinoma with contrast enhanced ultrasound

Contrast-enhanced ultrasonography of renal cell carcinomas:compared to contrast-enhanced CT

The value of partial hepatectomy in the treatment of hilar cholangiocarcinoma